Australia markets close in 3 hours 6 minutes

Silk Road Medical, Inc (SILK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.28+1.38 (+7.30%)
At close: 04:00PM EDT
20.01 -0.27 (-1.33%)
After hours: 06:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 799.88M
Enterprise value 701.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.26
Price/book (mrq)5.43
Enterprise value/revenue 3.78
Enterprise value/EBITDA -15.08

Trading information

Stock price history

Beta (5Y monthly) 1.48
52-week change 3-56.00%
S&P500 52-week change 322.38%
52-week high 343.51
52-week low 36.08
50-day moving average 317.65
200-day moving average 315.01

Share statistics

Avg vol (3-month) 3745.01k
Avg vol (10-day) 3718.41k
Shares outstanding 539.44M
Implied shares outstanding 639.44M
Float 838.33M
% held by insiders 15.89%
% held by institutions 1106.26%
Shares short (15 Apr 2024) 44.14M
Short ratio (15 Apr 2024) 47.5
Short % of float (15 Apr 2024) 410.76%
Short % of shares outstanding (15 Apr 2024) 410.56%
Shares short (prior month 15 Mar 2024) 43.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -28.80%
Operating margin (ttm)-30.80%

Management effectiveness

Return on assets (ttm)-13.99%
Return on equity (ttm)-35.04%

Income statement

Revenue (ttm)185.49M
Revenue per share (ttm)4.76
Quarterly revenue growth (yoy)20.80%
Gross profit (ttm)N/A
EBITDA -54.62M
Net income avi to common (ttm)-53.42M
Diluted EPS (ttm)-1.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)174.46M
Total cash per share (mrq)4.44
Total debt (mrq)83.69M
Total debt/equity (mrq)56.82%
Current ratio (mrq)11.05
Book value per share (mrq)3.75

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A